From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors

Por Draghiciu, Oana, Nijman, Hans W., Daemen, Toos
Publicado em 2011

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy

Por Draghiciu, Oana, Lubbers, Joyce, Nijman, Hans W, Daemen, Toos
Publicado no Oncoimmunology (2015)

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

Por Draghiciu, Oana, Nijman, Hans W, Hoogeboom, Baukje Nynke, Meijerhof, Tjarko, Daemen, Toos
Publicado no Oncoimmunology (2015)

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

Por Draghiciu, Oana, Boerma, Annemarie, Hoogeboom, Baukje Nynke, Nijman, Hans W, Daemen, Toos
Publicado no Oncoimmunology (2015)

Low body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate

Por Bouma, Hjalmar R., Kroese, Frans G. M., Kok, Jan Willem, Talaei, Fatimeh, Boerema, Ate S., Herwig, Annika, Draghiciu, Oana, van Buiten, Azuwerus, Epema, Anne H., van Dam, Annie, Strijkstra, Arjen M., Henning, Robert H.
Publicado em 2011